Table 5.
Plasma cyclocondensation means by sulforaphane (SF) and placebo group for each visit
| SF group N |
SF group nmol DTC/mLa Mean (SD) |
PL group N |
PL group nmol DTC/mLa Mean (SD) |
p valueb | |
|---|---|---|---|---|---|
| Week 0 | 21 | 0.007 (0.008) | 24 | 0.006 (0.008) | 0.614 |
| Week 7 | 21 | 0.299 (0.297) | 22 | 0.003 (0.005) | < 0.0001 |
| Week 15 | 21 | 0.329 (0.350) | 24 | 0.005 (0.008) | < 0.0001 |
| Week 22 | 19 | 0.248 (0.232) | 20 | 0.205 (0.253) | 0.582 |
| Week 30 | 22 | 0.165 (0.183) | 20 | 0.214 (0.228) | 0.451 |
| Week 36 | 15 | 0.015 (0.024) | 16 | 0.008 (0.012) | 0.286 |
Bold signifies p < 0.05
aDTC: dithiocarbamates, SF metabolites in plasma detected by cyclocondensation
bp values based on t test